Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT04789408 · TERMINATED
Trial details
- NCT number
- NCT04789408
- Sponsor
- Kite, A Gilead Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-19
- Primary completion
- 2024-05-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.